Consun Pharmaceutical Group Statistics

Total Valuation

Consun Pharmaceutical Group has a market cap or net worth of HKD 6.99 billion. The enterprise value is 4.00 billion.

Market Cap	6.99B
Enterprise Value	4.00B

Important Dates

The next estimated earnings date is Thursday, November 21, 2024.

Earnings Date	Nov 21, 2024
Ex-Dividend Date	Sep 5, 2024

Share Statistics

Consun Pharmaceutical Group has 826.88 million shares outstanding. The number of shares has increased by 1.69% in one year.

Current Share Class	n/a
Shares Outstanding	826.88M
Shares Change (YoY)	+1.69%
Shares Change (QoQ)	+1.15%
Owned by Insiders (%)	45.82%
Owned by Institutions (%)	7.28%
Float	405.12M

Valuation Ratios

The trailing PE ratio is 7.59 and the forward PE ratio is 7.09.

PE Ratio	7.59
Forward PE	7.09
PS Ratio	2.29
PB Ratio	1.75
P/TBV Ratio	n/a
P/FCF Ratio	7.81
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 3.87, with an EV/FCF ratio of 4.48.

EV / Earnings	4.46
EV / Sales	1.36
EV / EBITDA	3.87
EV / EBIT	4.22
EV / FCF	4.48

Financial Position

The company has a current ratio of 3.06, with a Debt / Equity ratio of 0.13.

Current Ratio	3.06
Quick Ratio	2.78
Debt / Equity	0.13
Debt / EBITDA	0.54
Debt / FCF	0.62
Interest Coverage	32.19

Financial Efficiency

Return on equity (ROE) is 22.16% and return on invested capital (ROIC) is 12.79%.

Return on Equity (ROE)	22.16%
Return on Assets (ROA)	10.49%
Return on Capital (ROIC)	12.79%
Revenue Per Employee	926,064
Profits Per Employee	282,792
Employee Count	3,127
Asset Turnover	0.52
Inventory Turnover	2.00

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +83.59% in the last 52 weeks. The beta is 0.62, so Consun Pharmaceutical Group's price volatility has been lower than the market average.

Beta (5Y)	0.62
52-Week Price Change	+83.59%
50-Day Moving Average	7.60
200-Day Moving Average	6.24
Relative Strength Index (RSI)	57.56
Average Volume (20 Days)	2,305,724

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Consun Pharmaceutical Group had revenue of HKD 2.94 billion and earned 898.71 million in profits. Earnings per share was 1.11.

Revenue	2.94B
Gross Profit	2.18B
Operating Income	948.69M
Pretax Income	988.60M
Net Income	898.71M
EBITDA	1.03B
EBIT	948.69M
Earnings Per Share (EPS)	1.11

Full Income Statement

Balance Sheet

The company has 3.85 billion in cash and 553.81 million in debt, giving a net cash position of 3.29 billion or 3.98 per share.

Cash & Cash Equivalents	3.85B
Total Debt	553.81M
Net Cash	3.29B
Net Cash Per Share	3.98
Equity (Book Value)	4.29B
Book Value Per Share	4.82
Working Capital	3.07B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 983.53 million and capital expenditures -88.87 million, giving a free cash flow of 894.65 million.

Operating Cash Flow	983.53M
Capital Expenditures	-88.87M
Free Cash Flow	894.65M
FCF Per Share	1.08

Full Cash Flow Statement

Margins

Gross margin is 74.22%, with operating and profit margins of 32.24% and 30.54%.

Gross Margin	74.22%
Operating Margin	32.24%
Pretax Margin	33.59%
Profit Margin	30.54%
EBITDA Margin	34.88%
EBIT Margin	32.24%
FCF Margin	30.40%

Dividends & Yields

This stock pays an annual dividend of 0.60, which amounts to a dividend yield of 7.08%.

Dividend Per Share	0.60
Dividend Yield	7.08%
Dividend Growth (YoY)	100.00%
Years of Dividend Growth	1
Payout Ratio	67.96%
Buyback Yield	-1.69%
Shareholder Yield	5.39%
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Consun Pharmaceutical Group has an Altman Z-Score of 4.07.

Altman Z-Score	4.07
Piotroski F-Score	n/a